![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:1348695 | 6480464 | epigallocatechin gallate results in decreased expression of EHD2 protein | CTD | PMID:31195006 | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 | 1,2-dichloroethane | decreases expression | ISO | RGD:1557952 | 6480464 | ethylene dichloride results in decreased expression of EHD2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1557952 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of EHD2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1348695 | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of EHD2 mRNA | CTD | PMID:20660070 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557952 | 6480464 | Tetrachlorodibenzodioxin affects the expression of EHD2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EHD2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of EHD2 mRNA | CTD | PMID:34747641 | 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1557952 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of EHD2 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1557952 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of EHD2 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1348695 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of EHD2 protein | CTD | PMID:34186270 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1557952 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of EHD2 gene | CTD | PMID:31683443 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1557952 | 6480464 | Fenretinide results in decreased expression of EHD2 mRNA | CTD | PMID:28973697 | 5-fluorouracil | affects response to substance | ISO | RGD:1348695 | 6480464 | EHD2 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of EHD2 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | increases expression | ISO | RGD:1557952 | 6480464 | Tretinoin results in increased expression of EHD2 mRNA | CTD | PMID:16788091 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EHD2 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | ISO | RGD:1348695 | 6480464 | Antirheumatic Agents results in increased expression of EHD2 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | affects methylation | ISO | RGD:1348695 | 6480464 | Benzo(a)pyrene affects the methylation of EHD2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1348695 | 6480464 | Benzo(a)pyrene results in increased expression of EHD2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | ISO | RGD:1348695 | 6480464 | Benzo(a)pyrene results in increased methylation of EHD2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | RGD:1348695 | 6480464 | Benzo(a)pyrene results in decreased methylation of EHD2 5' UTR | CTD | PMID:27901495 | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EHD2 mRNA | CTD | PMID:18164116 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1348695 | 6480464 | Diethylhexyl Phthalate results in increased expression of EHD2 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EHD2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | ISO | RGD:1557952 | 6480464 | bisphenol A results in increased expression of EHD2 mRNA | CTD | PMID:30951980, PMID:32156529 | Bisphenol B | increases expression | ISO | RGD:1348695 | 6480464 | bisphenol B results in increased expression of EHD2 protein | CTD | PMID:34186270 | bisphenol F | increases expression | ISO | RGD:1557952 | 6480464 | bisphenol F results in increased expression of EHD2 mRNA | CTD | PMID:30951980 | bisphenol F | increases expression | ISO | RGD:1348695 | 6480464 | bisphenol F results in increased expression of EHD2 protein | CTD | PMID:34186270 | bleomycin A2 | decreases expression | EXP | | 6480464 | Bleomycin results in decreased expression of EHD2 protein | CTD | PMID:25933445 | cadmium atom | multiple interactions | ISO | RGD:1348695 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EHD2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1348695 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EHD2 mRNA | CTD | PMID:35301059 | caffeine | decreases expression | ISO | RGD:1348695 | 6480464 | Caffeine results in decreased expression of EHD2 protein | CTD | PMID:31195006 | calcium dichloride | increases expression | ISO | RGD:1348695 | 6480464 | Calcium Chloride results in increased expression of EHD2 protein | CTD | PMID:25824407 | carbon nanotube | affects expression | ISO | RGD:1557952 | 6480464 | Nanotubes, Carbon affects the expression of EHD2 protein | CTD | PMID:21135415 | carbon nanotube | decreases expression | ISO | RGD:1557952 | 6480464 | Nanotubes, Carbon results in decreased expression of EHD2 protein | CTD | PMID:34864091 | carbon nanotube | increases expression | ISO | RGD:1557952 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | RGD:1348695 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to EHD2 gene] | CTD | PMID:28238834 | cobalt dichloride | decreases expression | ISO | RGD:1348695 | 6480464 | cobaltous chloride results in decreased expression of EHD2 mRNA | CTD | PMID:19320972 | cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of EHD2 mRNA | CTD | PMID:17898221 | copper(II) sulfate | increases expression | ISO | RGD:1348695 | 6480464 | Copper Sulfate results in increased expression of EHD2 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | RGD:1348695 | 6480464 | coumarin results in increased phosphorylation of EHD2 protein | CTD | PMID:35688186 | diazinon | increases methylation | ISO | RGD:1348695 | 6480464 | Diazinon results in increased methylation of EHD2 gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of EHD2 mRNA | CTD | PMID:21266533 | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of EHD2 mRNA | CTD | PMID:21658437 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of EHD2 mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | RGD:1348695 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | affects expression | ISO | RGD:1348695 | 6480464 | Doxorubicin affects the expression of EHD2 mRNA | CTD | PMID:29803840 | elemental selenium | increases expression | ISO | RGD:1348695 | 6480464 | Selenium results in increased expression of EHD2 mRNA | CTD | PMID:19244175 | entinostat | multiple interactions | ISO | RGD:1348695 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EHD2 mRNA | CTD | PMID:27188386 | entinostat | increases expression | ISO | RGD:1348695 | 6480464 | entinostat results in increased expression of EHD2 mRNA | CTD | PMID:26272509, PMID:27188386 | ethanol | multiple interactions | ISO | RGD:1348695 | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EHD2 mRNA | CTD | PMID:29432896 | fenamidone | increases expression | ISO | RGD:1557952 | 6480464 | fenamidone results in increased expression of EHD2 mRNA | CTD | PMID:27029645 | fluoranthene | multiple interactions | ISO | RGD:1557952 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EHD2 mRNA | CTD | PMID:28329830 | folic acid | decreases expression | ISO | RGD:1557952 | 6480464 | Folic Acid results in decreased expression of EHD2 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of EHD2 mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | RGD:1348695 | 6480464 | Ivermectin results in decreased expression of EHD2 protein | CTD | PMID:32959892 | lead diacetate | increases expression | ISO | RGD:1557952 | 6480464 | lead acetate results in increased expression of EHD2 mRNA | CTD | PMID:29746905 | lead(0) | affects expression | ISO | RGD:1348695 | 6480464 | Lead affects the expression of EHD2 mRNA | CTD | PMID:28903495 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of EHD2 mRNA | CTD | PMID:24136188 | lipopolysaccharide | multiple interactions | ISO | RGD:1348695 | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of EHD2 mRNA | CTD | PMID:35877022 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of EHD2 mRNA | CTD | PMID:28801915 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EHD2 mRNA | CTD | PMID:18164116 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of EHD2 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of EHD2 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | RGD:1557952 | 6480464 | Acetaminophen affects the expression of EHD2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of EHD2 mRNA | CTD | PMID:33387578 | pirinixic acid | decreases expression | ISO | RGD:1557952 | 6480464 | pirinixic acid results in decreased expression of EHD2 mRNA | CTD | PMID:20813756 | potassium dichromate | increases expression | ISO | RGD:1348695 | 6480464 | Potassium Dichromate results in increased expression of EHD2 protein | CTD | PMID:23718831 | progesterone | multiple interactions | ISO | RGD:1348695 | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of EHD2 mRNA | CTD | PMID:20660070 | resveratrol | multiple interactions | ISO | RGD:1348695 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of EHD2 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | RGD:1348695 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | increases expression | ISO | RGD:1348695 | 6480464 | Selenium results in increased expression of EHD2 mRNA | CTD | PMID:19244175 | silicon dioxide | increases expression | ISO | RGD:1557952 | 6480464 | Silicon Dioxide results in increased expression of EHD2 mRNA | CTD | PMID:19073995 | silver atom | decreases expression | ISO | RGD:1557952 | 6480464 | Silver results in decreased expression of EHD2 mRNA | CTD | PMID:19429238 | silver(0) | decreases expression | ISO | RGD:1557952 | 6480464 | Silver results in decreased expression of EHD2 mRNA | CTD | PMID:19429238 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of EHD2 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | RGD:1557952 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EHD2 mRNA | CTD | PMID:26378955 | sunitinib | decreases expression | ISO | RGD:1348695 | 6480464 | Sunitinib results in decreased expression of EHD2 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | RGD:1348695 | 6480464 | Temozolomide results in decreased expression of EHD2 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of EHD2 mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of EHD2 mRNA | CTD | PMID:25729387 | tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of EHD2 mRNA | CTD | PMID:21683754 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of EHD2 mRNA | CTD | PMID:33387578 | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of EHD2 protein | CTD | PMID:32519852 | tris(2-butoxyethyl) phosphate | affects expression | ISO | RGD:1348695 | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of EHD2 mRNA | CTD | PMID:29024780 | valproic acid | decreases expression | ISO | RGD:1348695 | 6480464 | Valproic Acid results in decreased expression of EHD2 mRNA | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | RGD:1348695 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EHD2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:1348695 | 6480464 | Valproic Acid results in increased expression of EHD2 mRNA | CTD | PMID:23179753 more ... | valproic acid | increases expression | ISO | RGD:1557952 | 6480464 | Valproic Acid results in increased expression of EHD2 mRNA | CTD | PMID:24896083 | valproic acid | increases methylation | ISO | RGD:1348695 | 6480464 | Valproic Acid results in increased methylation of EHD2 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1557952 | 6480464 | Valproic Acid affects the expression of EHD2 mRNA | CTD | PMID:17963808 | valproic acid | affects expression | ISO | RGD:1348695 | 6480464 | Valproic Acid affects the expression of EHD2 mRNA | CTD | PMID:25979313 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of EHD2 mRNA | CTD | PMID:22570695 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of EHD2 mRNA | CTD | PMID:19015723 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of EHD2 mRNA | CTD | PMID:23034163 | vitamin E | increases expression | ISO | RGD:1348695 | 6480464 | Vitamin E results in increased expression of EHD2 mRNA | CTD | PMID:19244175 | |